<\/b><\/p>\n
<\/b><\/p>\n
Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n
Recent Increase Seen in COVID-19 Incidence Among 18- to 22-Year-Olds<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — During Aug. 2 to Sept. 5, 2020, there was a 55.1 percent increase in the weekly incidence of COVID-19 nationally among young adults aged 18 to 22 years, according to research published in the Sept. 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19-Related Hospital Death Up With Psychiatric Diagnosis<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Patients with any prior psychiatric diagnosis have an increased risk for COVID-19-related hospital death, according to a research letter published online Sept. 30 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19 Tests for Return to Work May Delay Health Workers<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Health care workers (HCWs) diagnosed with COVID-19 can have a prolonged recovery of viral RNA, which can delay return to work (RTW), according to research published online Aug. 26 in Infection Control & Hospital Epidemiology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Current Trends in COVID-19 Reported for U.S. Youth<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research published in the Sept. 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n No Race Difference Found in COVID-19 Mortality Rates at Same Medical Center<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and Hispanic patients versus non-Hispanic White patients, according to a study published online Sept. 25 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Disparities in CVD Burden Increasing Between Richest, Poorer<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — There are substantial and increasing disparities in the prevalence of cardiovascular disease (CVD) among the highest-resource group and the remainder of the U.S. population, according to a study published online Sept. 25 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Hospital Admissions Not Related to COVID-19 Fell in Early 2020<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n AI Model Shows Deep Learning Can Detect Large Vessel Occlusion<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — A deep learning model can detect large vessel occlusion (LVO) using multiphase computed tomography (CT) angiography, according to a study published online Sept. 29 in Radiology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n U.S. Government to Ship Millions of Rapid COVID-19 Tests This Week<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Global Death Toll From COVID-19 Passes 1 Million<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The global COVID-19 pandemic reached a grim new milestone on Tuesday: 1 million dead.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Johns Hopkins University<\/a><\/p>\n Frequency of Alcohol Consumption Up During Pandemic<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — There has been an increase in the frequency of alcohol consumption from before to during the COVID-19 pandemic, according to a research letter published online Sept. 29 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Women With AMI-Cardiogenic Shock Treated Less Aggressively<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — Among young adults with acute myocardial infarction-cardiogenic shock (AMI-CS), women are treated less aggressively and have higher in-hospital mortality than men, according to a study published online Sept. 29 in Circulation: Heart Failure<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Health Care Use, Costs Increase 20-Fold After Firearm Injury<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — Actual health care costs increase up to 20-fold in the six months after a gunshot injury versus the six months before, according to a study published online Sept. 29 in the Annals of Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n New FDA Applications for Opioids Often Based on Short Trials<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — New drug applications (NDAs) for prescription opioids for pain have been based on pivotal trials of short or intermediate duration, often in narrowly defined pain populations, according to a study published online Sept. 29 in the Annals of Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Private Health Plans Pay Hospitals 247 Percent of Medicare<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.<\/p>\n More Information<\/a><\/p>\n Outcomes of In-Hospital Cardiac Arrest Poor in COVID-19 Patients<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — None of 54 patients hospitalized with COVID-19 with in-hospital cardiac arrest who underwent cardiopulmonary resuscitation (CPR) survived to discharge, according to a research letter published online Sept. 28 in JAMA Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Brain-Eating Amoeba Found in Tap Water of Lake Jackson, Texas<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — The presence of a brain-eating amoeba in its drinking water has led the city of Lake Jackson, Texas, to issue a “do not use water order” and request an emergency declaration from the state.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n Clinical Severity Lower With Vitamin D Sufficiency in COVID-19<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n <10 Percent of U.S. Population Has Antibodies to SARS-CoV-2<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Fewer than 10 percent of the U.S. adult population formed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the pandemic, according to a study published online Sept. 25 in The Lancet<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Wood Ear Mushrooms Linked to Salmonella<\/i> Outbreak<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Recalled wood ear mushrooms imported by Wismettac Asian Foods Inc., of Santa Fe Springs, California, and sold to restaurants may be linked to a multistate Salmonella<\/i> outbreak, the U.S. Food and Drug Administration said Thursday.<\/p>\n More Information<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Performance of Commercial SARS-CoV-2 Ab Tests Varies<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — There is considerable variation in the performance of commercial kits for detecting antibodies against SARS-CoV-2, according to a study published online Sept. 24 in PLOS Pathogens<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Median Age of COVID-19 Cases Declined in May to August in U.S.<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — From May to August 2020, there was a decrease in the median age of COVID-19 cases in the United States, according to research published in the Sept. 23 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n HRRP Tied to Decrease in 30-Day Readmission Rates for COPD<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — For patients with chronic obstructive pulmonary disease (COPD), implementation of the Hospital Readmissions Reduction Program (HRRP) is associated with a reduction in 30-day readmissions but may increase mortality, according to a study published online Sept. 1 in the American Journal of Respiratory and Critical Care Medicine<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Stroke ‘Alarm Clock’ Improves Acute Stroke Management Metrics<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — Use of a stroke alarm clock demanding active feedback significantly improves management metrics for acute stroke, according to a study published online Sept. 24 in Stroke<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Acute Kidney Injury Ups Risk for Death in COVID-19 Patients<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with a significantly higher risk for in-hospital death, according to a study published online Sept. 19 in the American Journal of Kidney Diseases<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season. HD Live! spoke with Nadia Eltaki, M.D., director of clinical operations at Sibley Memorial Hospital in Washington, D.C., to discuss how clinicians can potentially lessen the potential for an overlapping superinfection, or “twindemic.”<\/p>\n More Information<\/a><\/p>\n J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The final stage of clinical trials for Johnson & Johnson’s COVID-19 vaccine have started, the company announced Tuesday.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Stricter Vaccine Approval Rules Coming From FDA<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The U.S. COVID-19 death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in new cases. Just last Monday, only nine states were reporting increases in new COVID-19 cases, CNN<\/i> reported. For the most part, the case spikes are showing up in the country’s heartland and the Midwest.<\/p>\n CNN<\/i> Article<\/a><\/p>\n Red Blood Cell Distribution Width, Mortality Tied in COVID-19<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study published online Sept. 23 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n SARS-CoV-2 Mortality Mainly Linked to Older Age, Comorbidity<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For U.S. veterans with COVID-19, mortality is mainly associated with older age, male sex, and comorbidity, according to a study published online Sept. 23 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Most People With SARS-CoV-2 Do Not Remain Asymptomatic<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n AKI Occurs in 7 Percent of Those Hospitalized With COVID-19<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Rates of COVID-19 Infection Higher in Blacks, Hispanics<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Perrigo Asthma Inhalers Recalled Due to Clog Risk<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.<\/p>\n More Information<\/a><\/p>\n 1998 to 2016 Saw Rise in Alcohol Use Disorder Hospitalizations<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Alcohol use disorder (AUD) hospitalizations increased from 1998 to 2016, while in-hospital mortality for patients hospitalized with AUD decreased, according to a research letter published online Sept. 21 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Rates of Recurrent MI Declined Among U.S. Women and Men<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — From 2008 to 2017, there were decreases in the rates of recurrent myocardial infarction (MI), recurrent coronary heart disease (CHD) events, heart failure hospitalization, and all-cause mortality in both men and women, according to a study published online Sept. 21 in Circulation<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Mental Illness Recognition Up in U.K. General Hospital Admissions<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — From 2006 to 2017, there was improvement in the sensitivity for recording of severe mental illness (SMI) diagnosis in English general hospitals, but less accurate diagnostic recording was seen for some groups including ethnic minorities, according to a study published online Sept. 17 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19 Death Toll Nears 200,000 in the United States<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — As the U.S. COVID-19 case count neared 200,000 on Monday, public health experts debated whether the spread of the virus will continue to slow or a new surge will come, as cold weather returns to much of the country.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n AstraZeneca Releases COVID-19 Vaccine Trial Plans<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts are worried that an unproven or unsafe vaccine may be released prematurely due to pressure from President Donald Trump, The New York Times<\/i> reported.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n CDC Removes New COVID-19 Guidelines Just Days After Posting Them<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — New U.S. Centers for Disease Control and Prevention website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.<\/p>\n The Washington Post<\/i> Article<\/a><\/p>\n Peanut-, Tree Nut-Induced Anaphylaxis Up on Halloween, Easter<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — Among Canadian children, the risk for anaphylaxis induced by unknown nuts and peanuts is increased during Halloween and Easter, according to a study published online Sept. 21 in CMAJ<\/i>, the journal of the Canadian Medical Association.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Injuries Associated With Glass Tables Common in U.S.<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — Injuries associated with glass tables are common, and more than half are attributed to faulty tables, according to a study recently published in the American Journal of Surgery<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n